Metabolic abnormalities associated with elevated serum cystatin C in adults with an estimated GFR ≥ 60 ml/min/1.73m 2
暂无分享,去创建一个
J. Coresh | C. Fox | P. Muntner | J. Uribarri | S. Vupputuri | J. Coresh
[1] Devin Mann,et al. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. , 2008, The American journal of medicine.
[2] C. Schmid,et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] A. Köttgen,et al. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] J. Griffith,et al. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] J. Kaufman,et al. Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.
[6] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[7] Samuele M. Marcora,et al. GFR estimation using cystatin C is not independent of body composition. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] L. Stevens,et al. Serum cystatin C as a marker of glomerular filtration rate , 2006, Current opinion in nephrology and hypertension.
[9] B. Kestenbaum,et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease , 2006, Annals of Internal Medicine.
[10] Tom Greene,et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.
[11] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[12] K. Mehta,et al. Mortality risk stratification in chronic kidney disease: one size for all ages? , 2006, Journal of the American Society of Nephrology : JASN.
[13] T. Larson,et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations. , 2006, Kidney international.
[14] S. Cummings,et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. , 2005, Journal of the American Society of Nephrology : JASN.
[15] D. Siscovick,et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. , 2005, The New England journal of medicine.
[16] J. Manson,et al. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.
[17] A. Folsom,et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. , 2005, Journal of the American Society of Nephrology : JASN.
[18] M. Pepe,et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.
[19] D. Spiegelman,et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.
[20] B. Astor,et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. , 2004, Kidney international.
[21] N. Powe,et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. , 2004, JAMA.
[22] P. Whelton,et al. The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease , 2004, Annals of Internal Medicine.
[23] G. Spinas,et al. Serum cystatin C is sensitive to small changes in thyroid function. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[24] C. Zoccali,et al. Fibrinogen, mortality and incident cardiovascular complications in end‐stage renal failure , 2003, Journal of internal medicine.
[25] G. Chertow,et al. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] V. Dharnidharka,et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] B. Astor,et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.
[28] Tom Greene,et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] C. Price,et al. Cystatin C: an improved estimator of glomerular filtration rate? , 2002, Clinical chemistry.
[30] J. Kos,et al. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[31] I. Rosenberg,et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.